CD44 and nonpapillary renal cell carcinoma: To further investigate the prognostic value of CSC markers in ccRCC, we selected CD44 as a target because evidence indicated that CD44 was involved in tumor progression in ccRCC.33, 34 As shown in Figure 6f, we observed different intensities of immunostaining in tumor samples.